Bulletin from Swedish Orphan Biovitrum (Sobi)’s Extraordinary General Meeting (EGM)
The Sobi® EGM was convened today on 15 August 2023. At the EGM, the shareholders, in accordance with the proposed resolutions, resolved as follows:Authorisation for the Board of Directors to resolve on a new issue of common shares The EGM resolved to authorise the Board of Directors to, during the period up to the Annual General Meeting 2024, resolve on issue of new common shares with preferential rights for the company’s shareholders. The total number of shares that may be issued shall amount to the number of shares that corresponds to issue proceeds of approximately SEK 6,000,000,000